Skip to main content

Table 5 Adverse events

From: First-in-human study of TK-positive oncolytic vaccinia virus delivered by adipose stromal vascular fraction cells

Adverse events

Number

%

Related

Resolved

Skin rashes

8

40

Yes

Yes

Lipo- puncture bleeding

1

5

Yes

Yes

Fever (100.5 F)

2

10

No (10 days and 16 days a/t)

Yes

Pain

4

20

No (7 days, 10 days and 1 month a/t)

Yes

Hemoptysis

1

5

No (2 months a/t)

Yes

Pleural effusion

1

5

No (3 months a/t)

Yes

Headache and weakness of one side

1

5

No (3 weeks a/t)

Yes

Blood Transfusion

1

5

No (10 days a/t)

Yes

Pneumonia

1

5

No (16 days a/t)

Yes

  1. a/t: After treatment; pt: patient